Jupiter Bioscience Ltd.
NSE: JUPITER | BSE: 524826
₹3.97
₹-0.12
(-2.93%)
As on 15-Jan-2013IST
Market cap
₹25 Cr
Revenue (TTM)
₹168 Cr
P/E Ratio
--
P/B Ratio
0
Div. Yield
25.2 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-3 Cr
-
ROE
10 %
-
ROCE
8.8 %
-
Industry P/E
39.76
-
EV/EBITDA
6.4
-
Debt to Equity
0.6
-
Book Value
₹--
-
EPS
₹-0.4
-
Face value
10
-
Shares outstanding
62,433,470
10 Years Aggregate
CFO
₹456.34 Cr
EBITDA
₹624.73 Cr
Net Profit
₹254.92 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Jupiter Bioscience
| -11.2 | -26.1 | -34.4 | -66.7 | -65.7 | -53.4 | -21.9 |
|
BSE Sensex*
| -8.9 | 0.4 | 1.7 | -4.5 | 5.9 | 6.6 | 10.8 |
|
BSE Healthcare#
| 18.5 | 2.5 | 8.4 | 16.8 | 23.0 | 14.8 | 12.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Jupiter Bioscience
|
4.0 | 24.8 | 167.7 | -2.8 | 11.3 | -0.3 | -- | 0.0 |
| 3,270.2 | 26,812.8 | 1,461.8 | 387.4 | 34.5 | 25.2 | 69.4 | 15.5 | |
| 815.4 | 16,019.9 | 7,784.0 | 688.5 | 10.6 | 14 | 23.1 | 2.7 | |
| 450.3 | 17,243.7 | 2,141.5 | 58.5 | 5.8 | 3.3 | 162.3 | 4.5 | |
| 835.8 | 20,683.6 | 5,632.3 | 662.4 | 17.2 | 14.3 | 31.2 | 4.2 | |
| 1,526.2 | 17,533.5 | 1,543.3 | -48.6 | 3.6 | -0.6 | -- | 3.0 | |
| 219.2 | 28,990.1 | 9,205.3 | -371.8 | 1.7 | -3.8 | -- | 3.6 | |
| 1,834.3 | 30,370.1 | 1,935.8 | 288.2 | 20.6 | 29.8 | 105.4 | 22.6 | |
| 409.9 | 16,562.6 | 3,600.2 | 221.0 | 9.7 | 5.6 | 74.9 | 3.5 | |
| 2,028.0 | 32,764.1 | 3,564.0 | 414.0 | 15.3 | 8.4 | 80.1 | 6.5 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Research Desk
About Jupiter Bioscience
Manufacture of organic and inorganic chemical compounds n.e.c.
-
Incorporated
1985
-
Chairman
Venkat R Kalavakolanu
-
Managing Director
Venkat R Kalavakolanu
-
Headquarters
Bidar, Karnataka
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Jupiter Bioscience
What is the current share price of Jupiter Bioscience Ltd Today?
The share price of Jupiter Bioscience Ltd is ₹3.97 (BSE) and ₹4.15 (NSE) as of 15-Jan-2013 IST. Jupiter Bioscience Ltd has given a return of -65.66% in the last 3 years.
What is the current PB & PE ratio of Jupiter Bioscience Ltd?
Since, TTM earnings of Jupiter Bioscience Ltd is negative, P/E ratio is not available.
The P/B ratio of Jupiter Bioscience Ltd is 0.03 times as on 15-Jan-2013, a 99 discount to its peers’ median range of 4.21 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2011 |
2.49 |
0.18 |
2010 |
3.58 |
0.51 |
2009 |
1.83 |
0.25 |
2008 |
8.78 |
1.08 |
2007 |
7.02 |
1.60 |
What is the 52 Week High and Low of Jupiter Bioscience Ltd?
The 52-week high and low of Jupiter Bioscience Ltd are Rs -- and Rs -- as of 28-Aug-2026.
What is the market cap of Jupiter Bioscience Ltd?
Jupiter Bioscience Ltd has a market capitalisation of ₹ 25 Cr as on 15-Jan-2013. As per SEBI classification, it is a company.
Should I invest in Jupiter Bioscience Ltd?
Before investing in Jupiter Bioscience Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.